NO901303L - Nye benzotiopyranylaminer. - Google Patents

Nye benzotiopyranylaminer.

Info

Publication number: NO901303L
Authority: NO; Norway
Prior art keywords: benzotiopyrany; lamines; new; und; dieser verbindungen
Prior art date: 1989-03-22

Application number

NO90901303A

Other languages

English (en)

Other versions

NO901303D0 (no

NO174669C (no

NO174669B (no

Inventor

Alan J Hutchison

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-22

Filing date

1990-03-21

Publication date

1990-09-24

1990-03-21 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1990-03-21 Publication of NO901303D0 publication Critical patent/NO901303D0/no

1990-09-24 Publication of NO901303L publication Critical patent/NO901303L/no

1994-03-07 Publication of NO174669B publication Critical patent/NO174669B/no

1994-06-15 Publication of NO174669C publication Critical patent/NO174669C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)
Meat, Egg Or Seafood Products (AREA)
Tea And Coffee (AREA)
Indole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO901303A 1989-03-22 1990-03-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer NO174669C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US32694989A	1989-03-22	1989-03-22

Publications (4)

Publication Number	Publication Date
NO901303D0 NO901303D0 (no)	1990-03-21
NO901303L true NO901303L (no)	1990-09-24
NO174669B NO174669B (no)	1994-03-07
NO174669C NO174669C (no)	1994-06-15

Family

ID=23274473

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO901303A NO174669C (no)	1989-03-22	1990-03-21	Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer

Country Status (22)

Country	Link
US (1)	US5071858A (no)
EP (1)	EP0389425B1 (no)
JP (1)	JPH06102657B2 (no)
KR (1)	KR900014357A (no)
AT (1)	ATE121740T1 (no)
AU (1)	AU632318B2 (no)
CA (1)	CA2012569A1 (no)
DD (1)	DD292913A5 (no)
DE (1)	DE69018864D1 (no)
DK (1)	DK0389425T3 (no)
ES (1)	ES2071074T3 (no)
FI (1)	FI94863C (no)
GR (1)	GR3015938T3 (no)
HU (1)	HU206205B (no)
IE (1)	IE67871B1 (no)
IL (2)	IL93814A (no)
MX (1)	MX19953A (no)
NO (1)	NO174669C (no)
NZ (1)	NZ233002A (no)
PT (1)	PT93515B (no)
TW (1)	TW204347B (no)
ZA (1)	ZA902168B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06500099A (ja) *	1990-08-13	1994-01-06	ジー．ディー．サール　アンド　カンパニー	Ｃｎｓ疾病の処置におけるヘテロ環状アミノ―アルコール化合物の使用
FR2691149B1 (fr) *	1992-05-18	1994-07-08	Adir	Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5428307A (en) *	1993-10-20	1995-06-27	Silicon Systems, Inc.	Closed-loop peak detector topology
JPH0967367A (ja) *	1995-06-23	1997-03-11	Suntory Ltd	チオピラン誘導体
FR2739855B1 (fr) *	1995-10-13	1997-11-14	Adir	Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763335B1 (fr) *	1997-05-16	2000-11-24	Adir	Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050148018A1 (en) *	1999-10-07	2005-07-07	David Weiner	Methods of identifying inverse agonists of the serotonin 2A receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2077733B1 (no) *	1970-02-10	1973-03-16	Roussel Uclaf
GB1407552A (en) *	1973-04-02	1975-09-24	Science Union & Cie	Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
US4039676A (en) *	1975-06-23	1977-08-02	Ciba-Geigy Corporation	2-piperidinoalkyl-1,4-benzodioxans
US4468404A (en) *	1980-12-12	1984-08-28	Schering Corporation	3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
FI79535C (fi) *	1982-05-06	1990-01-10	Erba Farmitalia	Foerfarande foer framstaellning av dihydrobensopyrans och dihydrobensotiopyrans substituerade iminoderivat.
GB8515389D0 (en) *	1985-06-18	1985-07-17	Ici Plc	Heterocyclic compounds
ES2044970T3 (es) *	1986-06-26	1994-01-16	Ciba Geigy Ag	Procedimiento para la obtencion de compuestos hidrogenados del acido 1-benzooxacicloalquil-piridincarboxilico.
US4801605A (en) *	1986-08-29	1989-01-31	Ciba-Geigy Corporation	3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
GB8704572D0 (en) *	1987-02-26	1987-04-01	Lundbeck & Co As H	Organic compounds
EP0396620B1 (en) *	1988-01-15	1993-08-11	Abbott Laboratories	Aminomethyl-chroman and -thiochroman compounds
ES2100211T3 (es) *	1990-08-15	1997-06-16	Lilly Co Eli	2-amino-1,2,3,4-tetrahidronaftalenos, 3-aminocromanos y 3-aminotiocromanos sustituidos en el anillo.

1990
- 1990-03-13 EP EP90810193A patent/EP0389425B1/de not_active Expired - Lifetime
- 1990-03-13 ES ES90810193T patent/ES2071074T3/es not_active Expired - Lifetime
- 1990-03-13 DE DE69018864T patent/DE69018864D1/de not_active Expired - Fee Related
- 1990-03-13 AT AT90810193T patent/ATE121740T1/de not_active IP Right Cessation
- 1990-03-13 DK DK90810193.4T patent/DK0389425T3/da active
- 1990-03-19 FI FI901371A patent/FI94863C/fi not_active IP Right Cessation
- 1990-03-19 MX MX1995390A patent/MX19953A/es unknown
- 1990-03-20 IL IL9381590A patent/IL93814A/en not_active IP Right Cessation
- 1990-03-20 KR KR1019900003701A patent/KR900014357A/ko not_active Application Discontinuation
- 1990-03-20 JP JP2068565A patent/JPH06102657B2/ja not_active Expired - Lifetime
- 1990-03-20 CA CA002012569A patent/CA2012569A1/en not_active Abandoned
- 1990-03-20 PT PT93515A patent/PT93515B/pt not_active IP Right Cessation
- 1990-03-20 IL IL93814A patent/IL93814A0/xx unknown
- 1990-03-20 NZ NZ233002A patent/NZ233002A/en unknown
- 1990-03-20 DD DD90338904A patent/DD292913A5/de unknown
- 1990-03-21 NO NO901303A patent/NO174669C/no unknown
- 1990-03-21 IE IE103690A patent/IE67871B1/en not_active IP Right Cessation
- 1990-03-21 ZA ZA902168A patent/ZA902168B/xx unknown
- 1990-03-21 AU AU52086/90A patent/AU632318B2/en not_active Ceased
- 1990-03-21 HU HU901636A patent/HU206205B/hu not_active IP Right Cessation
- 1990-04-25 TW TW079103365A patent/TW204347B/zh active
- 1990-10-12 US US07/597,299 patent/US5071858A/en not_active Expired - Fee Related
1995
- 1995-04-27 GR GR950400873T patent/GR3015938T3/el unknown

Also Published As

Publication number	Publication date
EP0389425A1 (de)	1990-09-26
FI901371A0 (fi)	1990-03-19
CA2012569A1 (en)	1990-09-22
HU901636D0 (en)	1990-11-28
FI94863B (fi)	1995-07-31
NO901303D0 (no)	1990-03-21
IL93814A0 (en)	1990-12-23
PT93515A (pt)	1990-11-07
NO174669C (no)	1994-06-15
DD292913A5 (de)	1991-08-14
PT93515B (pt)	1996-08-30
DK0389425T3 (da)	1995-05-22
DE69018864D1 (de)	1995-06-01
HUT53632A (en)	1990-11-28
KR900014357A (ko)	1990-10-23
NZ233002A (en)	1992-07-28
ES2071074T3 (es)	1995-06-16
NO174669B (no)	1994-03-07
JPH037280A (ja)	1991-01-14
IE67871B1 (en)	1996-05-01
AU5208690A (en)	1990-11-08
TW204347B (no)	1993-04-21
EP0389425B1 (de)	1995-04-26
ZA902168B (en)	1990-11-28
IL93814A (en)	1995-07-31
HU206205B (en)	1992-09-28
GR3015938T3 (en)	1995-07-31
AU632318B2 (en)	1992-12-24
FI94863C (fi)	1995-11-10
MX19953A (es)	1994-01-31
US5071858A (en)	1991-12-10
IE901036L (en)	1990-09-22
ATE121740T1 (de)	1995-05-15
JPH06102657B2 (ja)	1994-12-14

Similar Documents

Publication	Publication Date	Title
ATE79264T1 (de)	1992-08-15	Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
ATE126433T1 (de)	1995-09-15	Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
NL300140I2 (nl)	2004-04-01	Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
DE3856594D1 (de)	2008-11-27	Mittel zur behandlung der alzheimer-krankheit
DE69115989D1 (de)	1996-02-15	Verwendung von 1-(2-Naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur Herstellung eines Medikaments zur Behandlung von zerebralen und neuronalen Krankheiten
DE3882775D1 (de)	1993-09-09	Zusammensetzung zur behandlung von parodontaler krankheit.
DE69130497D1 (de)	1998-12-24	Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE59302501D1 (de)	1996-06-13	Substituierte Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE69013880D1 (de)	1994-12-08	Verfahren und Vorrichtung zur Behandlung von Absorptionssuspensionen, die Flugasche beinhalten.
ATE6032T1 (de)	1984-02-15	Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten.
NO901303D0 (no)	1990-03-21	Nye benzotiopyranylaminer.
DE59208837D1 (de)	1997-10-09	Strahlungsempfindliches Gemisch, enthaltend säurelabile Gruppierungen und Verfahren zur Herstellung von Reliefmustern und Reliefbildern
DE59106745D1 (de)	1995-11-30	Strahlungsempfindliches Gemisch, hiermit hergestelltes strahlungsempfindliches Aufzeichnungsmaterial und Verfahren zur Herstellung von Reliefaufzeichnungen.
ATE135220T1 (de)	1996-03-15	Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose
DE69012808D1 (de)	1994-10-27	Vorrichtung zur behandlung von lebenden fischen und fischbrut und deren verwendung.
DE59003390D1 (de)	1993-12-16	Verfahren zur Herstellung von Butandiol-1,4 und Tetrahydrofuran.
ATE6643T1 (de)	1984-03-15	Neue 3,4-diaza-bicyclo(4.1.0)hepten-(2)-one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel.
DE3674213D1 (de)	1990-10-18	Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
ATA498381A (de)	1985-09-15	Verfahren zur herstellung von neuen 1,7,7-trimethylbicyclo(2.2.1)heptan-2-onoximaeth rn, diese verbindungen enthaltende pflanzenwachstumsregulierende mittel und verwendung der mittel
DE69000960D1 (de)	1993-04-01	Zusammensetzung zur behandlung von pigmentierung.
ATE106883T1 (de)	1994-06-15	Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
PT88572A (pt)	1988-10-01	Verfahren zur herstellung von neuen 7-diphenylmethyenbicycloheptanen und 7-diphenylmethylenbicycloheptenen und von pharmaezeutischen zusammensetzungen die diese enthalten
DE68914886D1 (de)	1994-06-01	Mittel zur Behandlung von Raynaud's Krankheit.
DE68914989D1 (de)	1994-06-01	Verfahren zur Behandlung und Entfärbung von Proteinlösungen, die Häm- und Chlorophyll-Pigmente enthalten, und entsprechende Produkte.
PT66533A (de)	1977-06-01	2-(dimethylcarbamoylimino)-1,3,4-thiadiazolin-3-carbons#ure-ester,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel